Darrin R. Uecker's most recent trade in Pulse Biosciences Inc was a trade of 100,000 Restricted Stock Units done . Disclosure was reported to the exchange on March 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2026 | 100,000 | 100,000 | - | - | Restricted Stock Units | |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.00 per share. | 16 Sep 2025 | 100,000 | 284,406 (1%) | 0% | 4 | 400,000 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2025 | 100,000 | 0 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2025 | 61,534 | 0 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.00 per share. | 16 Sep 2025 | 61,534 | 184,406 (0%) | 0% | 4 | 246,136 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2025 | 25,000 | 81,534 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 16.28 per share. | 16 Sep 2025 | 25,000 | 122,872 (0%) | 0% | 16.3 | 407,000 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.00 per share. | 16 Sep 2025 | 25,000 | 147,872 (0%) | 0% | 4 | 100,000 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 16.21 per share. | 16 Sep 2025 | 20,000 | 122,872 (0%) | 0% | 16.2 | 324,200 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.00 per share. | 16 Sep 2025 | 20,000 | 142,872 (0%) | 0% | 4 | 80,000 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2025 | 20,000 | 61,534 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2025 | 25,000 | 106,534 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2025 | 25,000 | 156,534 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 15.77 per share. | 11 Sep 2025 | 25,000 | 122,872 (0%) | 0% | 15.8 | 394,250 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.00 per share. | 11 Sep 2025 | 25,000 | 147,872 (0%) | 0% | 4 | 100,000 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 14.32 per share. | 11 Sep 2025 | 25,000 | 122,872 (0%) | 0% | 14.3 | 358,000 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.00 per share. | 11 Sep 2025 | 25,000 | 147,872 (0%) | 0% | 4 | 100,000 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 14.78 per share. | 11 Sep 2025 | 25,000 | 122,872 (0%) | 0% | 14.8 | 369,500 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.00 per share. | 11 Sep 2025 | 25,000 | 147,872 (0%) | 0% | 4 | 100,000 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2025 | 25,000 | 131,534 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 16.40 per share. | 12 Jun 2025 | 15,000 | 137,872 (0%) | 0% | 16.4 | 246,000 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 15.98 per share. | 12 Jun 2025 | 15,000 | 122,872 (0%) | 0% | 16.0 | 239,700 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | 12 Jun 2023 | 7,365 | 0 | - | - | Warrant (right to buy) | ||
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | 12 Jun 2023 | 7,365 | 148,941 (0%) | 0% | 2.0 | 15,098 | Common Stock | |
| Pulse Biosciences Inc | Darrin R. Uecker | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2023 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Darrin R. Uecker | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Jun 2022 | 7,365 | 7,365 | - | - | Warrant (right to buy) | |
| Pulse Biosciences Inc | Darrin R. Uecker | Director | 09 Jun 2022 | 7,365 | 137,376 (0%) | 0% | - | Common Stock |